Recent Updates
Recently added Catalysts
Trending News :
The freshest biotech headlines moving stocks right now, newest first.
Humacyte, Inc. Announces Pricing of Public Offering of Common Stock
HUMA ▼ 14.39%
Lisata Therapeutics Announces Commencement of Tender Offer by Kuva Labs Inc.
LSTA ▲ 9.83%
Harrow Re-Launches VERKAZIA® (cyclosporine ophthalmic emulsion) 0.1% for Vernal Keratoconjunctivitis, Addressing Significant Unmet Need in Pediatric Eyecare
HROW ▲ 6.10%
Accendra Health Announces Early Results of Offers and Consent Solicitations
ACH ▲ 2.62%
RadNet Secures $250 Million Incremental Term Loan to Fund Strategic Growth Opportunities and Reduces the Interest Rates on its Credit Facility by 0.25%
RDNT ▲ 2.37%BMGL to Effect Reverse Share Split on June 22, 2026
BMGL ▼ 18.48%Upcoming Catalysts That Could Move the Market
LB2501, associated with LEGN, is purportedly being (Read More)
AJ1-11095, also referred to as AJX-101, is an earl (Read More)
ELVN-001 is an oral, highly selective active-site (Read More)
Deucrictibant immediate-release capsule (PHVS416) (Read More)
Obicetrapib is an oral, once-daily, highly selecti (Read More)
Obicetrapib is an oral, once-daily, highly selecti (Read More)
Obicetrapib is an investigational, highly selectiv (Read More)
Venetoclax (VENCLEXTA®), marketed by AbbVie, is an (Read More)
Etentamig (ABBV-383) is an investigational BCMAxCD (Read More)
Latest Stocks News :
Humacyte, Inc. Announces Pricing of Public Offering of Common Stock
Humacyte, Inc. has announced the pricing of a public offering of 47,619,048 shares at $1.05 each, aiming to raise $50 million. The proceeds will be us [Read More]
MindWalk Holdings Corp. (NASDAQ : HYFT) lance ReefIQ™, une couche de contexte biologique au service de la découverte de médicaments par l’IA
MindWalk Holdings Corp. has launched ReefIQ™, a biological context layer aimed at enhancing drug discovery through AI. This initiative is expected to [Read More]
Cosmos Health CEO Issues Letter to Shareholders: Building an Innovative AI-Driven Global Healthcare Platform — Record Growth with U.S. Expansion Underway
Cosmos Health Inc. reported record revenue of $65.3 million for FY2025 and a strong start to Q1 2026. The company is actively expanding into the U.S. [Read More]
Cullinan Therapeutics Shares New Clinical Data Across Its Portfolio of T Cell Engager Programs Targeting CD19 and BCMA in Autoimmune Diseases
Cullinan Therapeutics has reported promising clinical data for its T cell engager programs, CLN-978 and velinotamig, targeting autoimmune diseases lik [Read More]
Danaher Completes Acquisition of Masimo Corporation
Danaher Corporation has successfully acquired Masimo Corporation, enhancing its diagnostics capabilities. Masimo will operate as a wholly-owned subsid [Read More]
TriSalus Life Sciences to Host Virtual KOL Event on June 24 Featuring New Real-World Evidence for Pressure-Enabled Drug Delivery™ in Liver Cancer
TriSalus Life Sciences is set to host a virtual Key Opinion Leader (KOL) event on June 24. The event will showcase new real-world evidence regarding t [Read More]